EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered Bacteria Factory Integrating Drug Delivery and Antibody Manufacture for Activating the STING Signal Pathway Mediated Tumor Immunotherapy

Peng-Shuo Dong, Tian Yao, Yong Li, Zi-Hui Yan, Xiao-Ting Xie, Jia-Hua Zou, Kai Cheng, Jin-Xuan Fan, Yuan-Di Zhao iD, Qiu-Ran Xu

Advanced Science · 2026

DOI: 10.1002/advs.202518172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Peng-Shuo Dong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Labora…. Hauptthemen laut MEDLINE: Immunotherapy, Drug Delivery Systems, Membrane Proteins, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Technology Innovation Program of Hubei Province, Natural Science Foundation of Hubei Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophages show great potential for application in cellular immunotherapy, but are limited by immune checkpoints (ICBs). Immune checkpoint inhibitors (ICIs) can effectively block immune escape pathways and alleviate immune suppression in the tumor microenvironment (TME). Here, we constructed hypoxia response bacteria (HRB) that specifically expressed CD47 antibody (aCD47) under hypoxic conditions in the TME, enabling the in situ synthesis of ICIs at the tumor site. In addition, this study further prepared responsive liposomes for encapsulating the STING agonist cGAMP and modified them by covalent attachment to the HRB surface to form the composite material HRB@LC. This composite system can synergistically block CD47‐SIRPα‐mediated immune escape and activate the STING signal pathway, thereby enhancing systemic antitumor immune responses and significantly improving the efficacy of immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyDrug Delivery SystemsMembrane ProteinsImmune Checkpoint InhibitorsAnimalscGAS-STING Signaling PathwayMiceTumor MicroenvironmentSignal TransductionCD47 AntigenHumansSTING Protein

Stichwörter der Autor:innen

STING signal pathwayengineered bacteriaimmune checkpoint inhibitorstumor immunotherapy

Substanzen

Membrane ProteinsImmune Checkpoint InhibitorsCD47 AntigenSTING Protein

Autor:innen und Institutionen

  • Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science an…
  • Department of Oncology, Huanggang Central Hospital of Yangtze University, Huanggang, Hubei, P.R. China.
  • Hubei Clinical Medical Research Center of Esophageal and Gastric Malignancy, Huanggang, Hubei, P.R. China.
  • Department of Chemistry, The Chinese University of Hong Kong, Hong Kong SAR, P.R. China.
  • Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People's Hospital Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, P. R. China.

ORCID-Profile: Yuan-Di Zhao

Förderung

  • National Natural Science Foundation of China
  • Technology Innovation Program of Hubei Province
  • Natural Science Foundation of Hubei Province of China
  • China Ageing Development Foundation-Elderly Navigation Program Research Fund

Zitieren

APA

Dong, P. S., Yao, T., Li, Y., Yan, Z. H., Xie, X. T., Zou, J. H., Cheng, K., Fan, J. X., Zhao, Y. D., & Xu, Q. R. (2026). Engineered Bacteria Factory Integrating Drug Delivery and Antibody Manufacture for Activating the STING Signal Pathway Mediated Tumor Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202518172

Vancouver

Dong PS, Yao T, Li Y, Yan ZH, Xie XT, Zou JH, et al. Engineered Bacteria Factory Integrating Drug Delivery and Antibody Manufacture for Activating the STING Signal Pathway Mediated Tumor Immunotherapy. Advanced Science. 2026. doi:10.1002/advs.202518172

BibTeX
@article{Dong2026,
  author = {Dong, Peng-Shuo and Yao, Tian and Li, Yong and Yan, Zi-Hui and Xie, Xiao-Ting and Zou, Jia-Hua and Cheng, Kai and Fan, Jin-Xuan and Zhao, Yuan-Di and Xu, Qiu-Ran},
  title = {Engineered Bacteria Factory Integrating Drug Delivery and Antibody Manufacture for Activating the STING Signal Pathway Mediated Tumor Immunotherapy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202518172}
}
Kostenlos starten →